64
Participants
Start Date
November 21, 2017
Primary Completion Date
August 24, 2018
Study Completion Date
April 29, 2019
Psorax35
This is a randomized, 32 weeks, single center, placebo controlled, double blind study to investigate Psorax35 supplementation in patients with mild to moderate Psoriasis. Groups of patients will be block randomized using randomly selected block sizes, and stratified according to gender.
MCT oil
This is a randomized, 32 weeks, single center, placebo controlled, double blind study to investigate Psorax35 supplementation in patients with mild to moderate Psoriasis. Groups of patients will be block randomized using randomly selected block sizes, and stratified according to gender.
Haukeland Universitetssjukehus, Bergen
University of Bergen
OTHER
Haukeland University Hospital
OTHER
Arctic Nutrition AS
INDUSTRY